R. Wesch

Effect of a single dose of insulin glargine/lixisenatide fixed ratio combination (iGlarLixi) on postprandial glucodynamic response in Japanese patients with type 2 diabetes mellitus: A phase I randomized trial

M. Lorenz, Megumi Inoue, Hideya Muto, 2019, Diabetes, obesity & metabolism.

Clinical Pharmacokinetic Studies 45

A. Frick, A. Steinstraesser, R. Wesch, 2013 .

Clinical Studies – Typical Designs

A. Frick, A. Steinstraesser, R. Wesch, 2006 .

Significant Pharmacokinetic and Pharmacodynamic Interaction of Warfarin With the NO‐Independent sGC Activator HMR1766

W. Haefeli, G. Mikus, K. Lehr, 2007, Journal of clinical pharmacology.

Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.

N. Vetter, E. Fiss, F. Maesen, 1999, The Journal of antimicrobial chemotherapy.

Pharmacogenomics in Drug Metabolizing Enzymes and Transporters

D. Weitz, Jochen Maas, R. Wesch, 2013 .

Pharmacogenomics in and Its Influence on Pharmacokinetics

Jochen Maas, G. Montay, R. Wesch, 2020, Drug Discovery and Evaluation: Methods in Clinical Pharmacology.

Pharmacokinetics of ticarcillin/clavulanate in severely burned patients.

P. Koeppe, D. Adam, R. Wesch, 1989, The Journal of antimicrobial chemotherapy.

Absolute and Relative Bioavailability

R. Wesch, 2011 .